2022
DOI: 10.1016/j.isci.2022.105331
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic data as an enabler for machine learning applications in medicine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
25
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 47 publications
(25 citation statements)
references
References 42 publications
0
25
0
Order By: Relevance
“…While there is a body of work on the synthesis of medical images and other data types [ 111 ], our focus in this paper was on structured longitudinal data. The synthesis of multi-modal data would be an important direction for future research.…”
Section: Discussionmentioning
confidence: 99%
“…While there is a body of work on the synthesis of medical images and other data types [ 111 ], our focus in this paper was on structured longitudinal data. The synthesis of multi-modal data would be an important direction for future research.…”
Section: Discussionmentioning
confidence: 99%
“…This data set can be used with any machine‐learning module, thus allowing other researchers to utilize it in their research. Synthetic data generation for machine‐learning is an active area of research, especially in the domain of medicine and health care, where the privacy of patient data is a big concern [3, 14, 22, 29, 40, 46]. To the best of our knowledge, no existing open‐source contribution automate the diagnosis of the three hearing loss attributes: type, degree, and configuration.…”
Section: Related Workmentioning
confidence: 99%
“…This data set can be used with any machine‐learning module, thus allowing other researchers to utilize it in their research. Synthetic data generation for machine‐learning is an active area of research, especially in the domain of medicine and health care, where the privacy of patient data is a big concern [3, 14, 22, 29, 40, 46].…”
Section: Related Workmentioning
confidence: 99%
“…These limitations represent a unique opportunity to develop in silico trials that are completed as planned, safely, and that include digital cohorts with a representative distribution of subject characteristics and numbers large enough for appropriate statistical power. As pointed out in [9], in silico data has the potential to address lack of data availability, sharing mechanisms and privacy challenges associated with the use of medical information.…”
Section: Introductionmentioning
confidence: 99%